Please login to Zacks.com or register to post a comment.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| NATUS MEDICA | BABY | 6.11% |
| SUMMER INFAN | SUMR | 6.02% |
| RADIANT LOGI | RLGT | 5.32% |
| NEW ORIENTAL | EDU | 4.51% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
The Federal Deposit Insurance Corp. (FDIC) has filed a lawsuit against major banks over the alleged sale of $388 million of risky mortgage-backed securities (MBS) to the failed Colonial Bank. Apart from attorney fees and court expenses, the FDIC is seeking $189 million in damages.
Colonial Bank-based in Montgomery, Alabama failed in August 2009 and was acquired by BB&T Corp. ( BBT - Analyst Report ) . At that time, Colonial Bank had nearly $25 billion in assets and the FDIC had estimated the cost to the federal deposit-insurance fund to be $2.8 billion.
The major lenders against whose units the FDIC filed the lawsuit include biggies like JPMorgan Chase & Co. ( JPM - Analyst Report ) , Bank of America Corporation ( BAC - Analyst Report ) , Citigroup Inc. ( C - Analyst Report ) , Wells Fargo & Company ( WFC - Analyst Report ) , Deutsche Bank AG ( DB - Snapshot Report ) , Credit Suisse Group ( CS - Snapshot Report ) , HSBC Holdings plc ( HBC - Analyst Report ) , UBS AG ( UBS - Analyst Report ) , Ally Financial Inc. and The Royal Bank of Scotland Group plc ( RBS ) , among others. The FDIC has alleged that the lenders distorted the facts related to the MBS they sold to Colonial Bank.
Moreover, the FDIC accused the banks of not disclosing authentic facts related to the quality of the underlying assets while selling risky MBS to Colonial Bank. This also included distortion of loan-to-value ratios that were based on the inflated property values. Further, the fact that a large number of these properties had second mortgages was also concealed.
The above-mentioned lawsuit is almost identical to the one that was filed by the U.S. Federal Housing Finance Agency (FHFA) against approximately a dozen big banks. The FHFA sued major banks for infringing commitments on the quality of about $196 billion MBS sold to Fannie Mae ( FNMA ) and Freddie Mac ( FMCC ) during the housing bubble.
The FDIC’s action comes as a major blow to the big banks that are already facing numerous litigations related to the sale of risky MBS. However, the investors and other financial institutions which suffered as a result of these faulty practices are expected to get a breather.
Read the full reports :
Analyst Report on JPM
Snapshot Report on CS
Analyst Report on BBT
Analyst Report on UBS
on FMCC
Snapshot Report on DB
Analyst Report on WFC
on RBS
Analyst Report on C
on FNMA
Analyst Report on BAC
Analyst Report on HBC